- Orgenesis ( NASDAQ: ORGS ) and Metalmark Capital Partners announced an investment partnership whereby Metalmark has agreed to make a growth investment of up to $50M in Orgenesis.
- The investment will be made at a pre-money valuation of $125M and will consist of an upfront investment of $30M and two future investments of $10M each.
- The initial investment of $30M will consist of $20M in cash and conversion of the convertible loan Metalmark previously provided to Morgenesis in August 2022.
- Morgenesis will use the investment to develop and expand its new POCare Services business globally, but with an initial focus on the US.
- Stock surges 26% on news.
For further details see:
Orgenesis jumps 26% on $50M investment from Metalmark Capital